5,000 sleep apnea patients join gene hunt

NCT ID NCT01857427

Ongoing Knowledge-focused Sponsor: Ulysses Magalang MD Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study aims to understand the genetic factors behind obstructive sleep apnea (OSA) and its related health issues. Researchers will enroll 5,000 adults who have been diagnosed with or are suspected of having sleep apnea. Participants will provide genetic samples and answer sleep questionnaires. The goal is to build a detailed database to help identify genes linked to OSA and its complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help identify genetic risk factors for sleep apnea, potentially leading to better screening or personalized treatments in the future.
What could go wrong: This is an observational study, not a treatment trial. It only collects data and does not test any therapy, so it cannot directly improve health. Results may take years to translate into clinical use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBSTRUCTIVE SLEEP APNEA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

obstructive sleep apnea syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBSTRUCTIVE SLEEP APNEA

Contacts and locations

Locations

Suite 2600, Martha Morehouse Medical Pavilion

Columbus, Ohio, 43221, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.